299 related articles for article (PubMed ID: 15310406)
1. The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.
Anson DS
Genet Vaccines Ther; 2004 Aug; 2(1):9. PubMed ID: 15310406
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
3. Integration target site selection for retroviruses and transposable elements.
Wu X; Burgess SM
Cell Mol Life Sci; 2004 Oct; 61(19-20):2588-96. PubMed ID: 15526164
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vectors for liver-directed gene therapy.
Kalpana GV
Semin Liver Dis; 1999; 19(1):27-37. PubMed ID: 10349681
[TBL] [Abstract][Full Text] [Related]
5. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Bartosch B; Cosset FL
Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
[TBL] [Abstract][Full Text] [Related]
6. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
7. Interactions between Retroviruses and the Host Cell Genome.
Poletti V; Mavilio F
Mol Ther Methods Clin Dev; 2018 Mar; 8():31-41. PubMed ID: 29159201
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of retroviral integration and mutagenesis.
Cavazza A; Moiani A; Mavilio F
Hum Gene Ther; 2013 Feb; 24(2):119-31. PubMed ID: 23330935
[TBL] [Abstract][Full Text] [Related]
9. Retroviral gene therapy: safety issues and possible solutions.
Yi Y; Hahm SH; Lee KH
Curr Gene Ther; 2005 Feb; 5(1):25-35. PubMed ID: 15638709
[TBL] [Abstract][Full Text] [Related]
10. Lentiviruses in gene therapy clinical research.
Connolly JB
Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
[TBL] [Abstract][Full Text] [Related]
11. Biosafety of onco-retroviral vectors.
VandenDriessche T; Collen D; Chuah MK
Curr Gene Ther; 2003 Dec; 3(6):501-15. PubMed ID: 14683449
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vectors for gene transfer.
Cornetta K; Pollok KE; Miller AD
CSH Protoc; 2008 Apr; 2008():pdb.top29. PubMed ID: 21356814
[TBL] [Abstract][Full Text] [Related]
13. Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.
Haviernik P; Bunting KD
Curr Gene Ther; 2004 Sep; 4(3):263-76. PubMed ID: 15384940
[TBL] [Abstract][Full Text] [Related]
14. Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
Bii VM; Trobridge GD
Cancers (Basel); 2016 Oct; 8(11):. PubMed ID: 27792127
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vectors and gene therapy.
Klimatcheva E; Rosenblatt JD; Planelles V
Front Biosci; 1999 Jun; 4():D481-96. PubMed ID: 10352135
[TBL] [Abstract][Full Text] [Related]
16. Effects of cell cycle status on early events in retroviral replication.
Katz RA; Greger JG; Skalka AM
J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
Doi K; Takeuchi Y
Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
[TBL] [Abstract][Full Text] [Related]
19. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
